Syncell Biotechnology has been selected to the Final Stage of The 2022 Eddies, in the Life Sciences Track.

 

SynCell News • May 25, 2022

SynCell Biotechnology has been selected as one of the finalists for this year competition at The Eddies.

Robert J. Crowley’s brain child, the New England Innovation Award competition was first launched in 1986, and since then, over 3,000 startups have been supported to succeed and scale.

Some notable alumni include Ben & Jerry’s Ice Cream, Staples, Genzyme, MassChallenge, Carbonite, KRONOS, ZipCar, iRobot, zipcar, Keurig and Vistaprint. Today, 37 years later, the program is a 7-month innovation-support system based on Individualized Mentoring, Strategic Guidance, Leadership Education, and Connections to Resources; its objective is to help early-stage startups (pre-Series C) take the next steps in their commercialization journey. In 2021, the program was rebranded as The Eddies.